Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
366. lappuse
... ( solution 1 as described in § 436.101 ) . This is the assay solution . ( d ) Procedure for assay . For the stand- ard ... sample solution ( 2 to 5 milliliters ) with 0.1 milliliter of penicillinase solution and incubate at 37 ° C. for 1 ...
... ( solution 1 as described in § 436.101 ) . This is the assay solution . ( d ) Procedure for assay . For the stand- ard ... sample solution ( 2 to 5 milliliters ) with 0.1 milliliter of penicillinase solution and incubate at 37 ° C. for 1 ...
382. lappuse
... sample solution ( the dif- ference is the equivalent of the number of milliliters of 0.01N iodine absorbed by the inactivated sample ) ; Wu - Actual weight in miligrams of sample in the 2.0 milliliters titrated . ( 3 ) Finished products ...
... sample solution ( the dif- ference is the equivalent of the number of milliliters of 0.01N iodine absorbed by the inactivated sample ) ; Wu - Actual weight in miligrams of sample in the 2.0 milliliters titrated . ( 3 ) Finished products ...
383. lappuse
... solution ) A2 × Milligrams of sample per milliliter of sample solution Dissolution medium 900 mL 0.10 M sodium phosphate buffer ,. Antibiotic Amoxicillin trihydrate Ampicillin Ampicillin sodium Ampicillin trihydrate Bacampicillin ...
... solution ) A2 × Milligrams of sample per milliliter of sample solution Dissolution medium 900 mL 0.10 M sodium phosphate buffer ,. Antibiotic Amoxicillin trihydrate Ampicillin Ampicillin sodium Ampicillin trihydrate Bacampicillin ...
384. lappuse
... sample , accurately weighed , in a tared porcelain crucible and carefully ignite at a low tempera- ture until ... solution . Prepare an aqueous solution contain- ing not less than 9 grams and not more than 10 grams of ammonia ( NH3 ) per ...
... sample , accurately weighed , in a tared porcelain crucible and carefully ignite at a low tempera- ture until ... solution . Prepare an aqueous solution contain- ing not less than 9 grams and not more than 10 grams of ammonia ( NH3 ) per ...
385. lappuse
... Sample preparation . If necessary , reduce the sample to a fine powder and store it in a desiccator over sulfuric ... solution at 25 ° C. and transfer to the appropriate polarimeter tube . Deter- mine the angular rotation of both sol- vent ...
... Sample preparation . If necessary , reduce the sample to a fine powder and store it in a desiccator over sulfuric ... solution at 25 ° C. and transfer to the appropriate polarimeter tube . Deter- mine the angular rotation of both sol- vent ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning